Vimpat 150 mg/1 (Lacosamide TABLET, FILM COATED) 150 mg/1

Vimpat 150 mg tablets are an anticonvulsant medication used to manage certain types of seizures. This film-coated tablet is designed for oral administration and is manufactured by UCB, Inc. in the USA.

Strength

150 mg/1

Pack Size

1 BLISTER PACK in 1 CARTON (0131-2479-99) / 14 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

UCB, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vimpat 150 mg tablets are primarily used as an adjunctive therapy for the treatment of partial-onset seizures in adults and children. Lacosamide, the active ingredient, is often prescribed to help control seizures when other medications are not fully effective. This medication is not typically used as a standalone treatment but works alongside other anticonvulsants to provide comprehensive seizure management.

Side Effects

Common effects of Vimpat 150 mg tablets may include dizziness, headache, and fatigue. Some users might experience nausea or double vision. These effects can vary from person to person and are generally mild to moderate in nature. It's important to monitor how the body responds to this medication and consult a healthcare provider if any effects are concerning.

Precautions & Warnings

Vimpat 150 mg tablets should be handled with care, especially for individuals with a history of heart conditions or psychiatric disorders. It is crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always store the medication in a cool, dry place away from direct sunlight and out of reach of children.

Avoid Interactions

Vimpat 150 mg tablets may interact with other medications, particularly those that affect the central nervous system. Alcohol and certain antidepressants can enhance the sedative effects of lacosamide. It's important to inform a healthcare provider about all current medications and supplements being taken to avoid potential interactions.

Frequently Asked Questions

Vimpat 150 mg tablets are used as an adjunctive therapy for managing partial-onset seizures in adults and children.

Vimpat 150 mg tablets are designed for oral administration. Follow the dosage and administration instructions provided by a healthcare professional.

Common side effects may include dizziness, headache, fatigue, nausea, and double vision.

Vimpat 150 mg may interact with other medications, especially those affecting the central nervous system. Consult a healthcare provider before combining with other treatments.

Store Vimpat 150 mg tablets in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.